JP7084410B2 - 体液を排出及び分析するためのシステム、デバイス及び方法 - Google Patents
体液を排出及び分析するためのシステム、デバイス及び方法 Download PDFInfo
- Publication number
- JP7084410B2 JP7084410B2 JP2019538523A JP2019538523A JP7084410B2 JP 7084410 B2 JP7084410 B2 JP 7084410B2 JP 2019538523 A JP2019538523 A JP 2019538523A JP 2019538523 A JP2019538523 A JP 2019538523A JP 7084410 B2 JP7084410 B2 JP 7084410B2
- Authority
- JP
- Japan
- Prior art keywords
- pressure
- urine
- lumen
- drainage
- balloon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title description 95
- 210000001124 body fluid Anatomy 0.000 title description 5
- 239000010839 body fluid Substances 0.000 title description 5
- 239000012530 fluid Substances 0.000 claims description 238
- 238000009423 ventilation Methods 0.000 claims description 59
- 238000005336 cracking Methods 0.000 claims description 19
- 239000012298 atmosphere Substances 0.000 claims description 12
- 230000008859 change Effects 0.000 claims description 11
- 210000002700 urine Anatomy 0.000 description 341
- 239000007789 gas Substances 0.000 description 155
- 210000003932 urinary bladder Anatomy 0.000 description 116
- 230000007246 mechanism Effects 0.000 description 104
- 238000005259 measurement Methods 0.000 description 89
- 230000002485 urinary effect Effects 0.000 description 88
- 239000007788 liquid Substances 0.000 description 68
- 239000012528 membrane Substances 0.000 description 62
- 210000004379 membrane Anatomy 0.000 description 56
- 238000009530 blood pressure measurement Methods 0.000 description 54
- 230000000747 cardiac effect Effects 0.000 description 49
- 230000036387 respiratory rate Effects 0.000 description 43
- 238000004891 communication Methods 0.000 description 40
- 239000000463 material Substances 0.000 description 40
- 201000011040 acute kidney failure Diseases 0.000 description 31
- 230000000241 respiratory effect Effects 0.000 description 31
- 230000009467 reduction Effects 0.000 description 30
- 238000004458 analytical method Methods 0.000 description 28
- 239000002934 diuretic Substances 0.000 description 27
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 26
- 229910052760 oxygen Inorganic materials 0.000 description 26
- 239000001301 oxygen Substances 0.000 description 26
- 238000005070 sampling Methods 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000011148 porous material Substances 0.000 description 21
- 238000007789 sealing Methods 0.000 description 21
- 238000011282 treatment Methods 0.000 description 21
- 238000001514 detection method Methods 0.000 description 20
- 230000001882 diuretic effect Effects 0.000 description 20
- 239000003814 drug Substances 0.000 description 20
- 229940079593 drug Drugs 0.000 description 20
- 230000002209 hydrophobic effect Effects 0.000 description 20
- 238000001802 infusion Methods 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 20
- 230000007423 decrease Effects 0.000 description 19
- 230000037452 priming Effects 0.000 description 19
- 206010040047 Sepsis Diseases 0.000 description 18
- 230000035485 pulse pressure Effects 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 208000015181 infectious disease Diseases 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 16
- 230000010412 perfusion Effects 0.000 description 16
- 230000014759 maintenance of location Effects 0.000 description 15
- 238000000576 coating method Methods 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 208000019206 urinary tract infection Diseases 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 238000012544 monitoring process Methods 0.000 description 13
- 210000000265 leukocyte Anatomy 0.000 description 12
- 238000012545 processing Methods 0.000 description 12
- 208000002623 Intra-Abdominal Hypertension Diseases 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 11
- 238000004364 calculation method Methods 0.000 description 11
- 230000029142 excretion Effects 0.000 description 11
- 230000005484 gravity Effects 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 210000002381 plasma Anatomy 0.000 description 11
- 238000005086 pumping Methods 0.000 description 11
- 230000008733 trauma Effects 0.000 description 11
- 230000003044 adaptive effect Effects 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 10
- 230000003247 decreasing effect Effects 0.000 description 10
- 210000003743 erythrocyte Anatomy 0.000 description 10
- 238000007912 intraperitoneal administration Methods 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- 230000003187 abdominal effect Effects 0.000 description 9
- 230000036760 body temperature Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 9
- 230000029058 respiratory gaseous exchange Effects 0.000 description 9
- 206010058808 Abdominal compartment syndrome Diseases 0.000 description 8
- 230000004872 arterial blood pressure Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 210000002414 leg Anatomy 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 210000003708 urethra Anatomy 0.000 description 8
- 210000001635 urinary tract Anatomy 0.000 description 8
- 238000009736 wetting Methods 0.000 description 8
- 208000009304 Acute Kidney Injury Diseases 0.000 description 7
- 230000002411 adverse Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 229940030606 diuretics Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 230000002572 peristaltic effect Effects 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000000287 tissue oxygenation Effects 0.000 description 7
- 238000002604 ultrasonography Methods 0.000 description 7
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 description 6
- 238000002106 pulse oximetry Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 241000490495 Barbarea Species 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 208000033626 Renal failure acute Diseases 0.000 description 5
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 5
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 238000009529 body temperature measurement Methods 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 230000000737 periodic effect Effects 0.000 description 5
- -1 polytetrafluoroethylene Polymers 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010046555 Urinary retention Diseases 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000036757 core body temperature Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000035487 diastolic blood pressure Effects 0.000 description 4
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000007667 floating Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000003434 inspiratory effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 210000000626 ureter Anatomy 0.000 description 4
- 238000004804 winding Methods 0.000 description 4
- 206010058040 Abdominal sepsis Diseases 0.000 description 3
- 229920002799 BoPET Polymers 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- 206010053879 Sepsis syndrome Diseases 0.000 description 3
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002631 hypothermal effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 230000000414 obstructive effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000003200 peritoneal cavity Anatomy 0.000 description 3
- 229920000052 poly(p-xylylene) Polymers 0.000 description 3
- 230000010349 pulsation Effects 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 206010061481 Renal injury Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 229960003883 furosemide Drugs 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000036724 intravesical pressure Effects 0.000 description 2
- 208000037806 kidney injury Diseases 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000005399 mechanical ventilation Methods 0.000 description 2
- 230000005499 meniscus Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 201000011461 pre-eclampsia Diseases 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000013125 spirometry Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 208000003918 Acute Kidney Tubular Necrosis Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108091005515 EGF module-containing mucin-like hormone receptors Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 238000004497 NIR spectroscopy Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010037394 Pulmonary haemorrhage Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 206010038540 Renal tubular necrosis Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 241000907335 Sal Vieja virus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
- 230000001269 cardiogenic effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000002079 electron magnetic resonance spectroscopy Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000003636 fecal output Effects 0.000 description 1
- 238000002637 fluid replacement therapy Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 108010000849 leukocyte esterase Proteins 0.000 description 1
- 239000002171 loop diuretic Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001690 micro-dialysis Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 210000003281 pleural cavity Anatomy 0.000 description 1
- 238000001874 polarisation spectroscopy Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000718 qrs complex Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000009531 respiratory rate measurement Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229940071575 silver citrate Drugs 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000004085 squamous epithelial cell Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- QUTYHQJYVDNJJA-UHFFFAOYSA-K trisilver;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ag+].[Ag+].[Ag+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QUTYHQJYVDNJJA-UHFFFAOYSA-K 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
- A61B5/036—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs by means introduced into body tracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/202—Assessing bladder functions, e.g. incontinence assessment
- A61B5/205—Determining bladder or urethral pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/207—Sensing devices adapted to collect urine
- A61B5/208—Sensing devices adapted to collect urine adapted to determine urine quantity, e.g. flow, volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/44—Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices
- A61F5/451—Genital or anal receptacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/74—Suction control
- A61M1/742—Suction control by changing the size of a vent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/74—Suction control
- A61M1/743—Suction control by changing the cross-section of the line, e.g. flow regulating valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/0071—Multiple separate lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M25/0075—Valve means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02444—Details of sensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M25/0075—Valve means
- A61M2025/0076—Unidirectional valves
- A61M2025/0078—Unidirectional valves for fluid inflow from the body into the catheter lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0286—Holding devices, e.g. on the body anchored in the skin by suture or other skin penetrating devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
- A61M2025/1015—Multiple balloon catheters having two or more independently movable balloons where the distance between the balloons can be adjusted, e.g. two balloon catheters concentric to each other forming an adjustable multiple balloon catheter system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0496—Urine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3344—Measuring or controlling pressure at the body treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Optics & Photonics (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Description
V:容積
A:断面積
h:液体の高さ
P:圧力
ρ:液体密度
g:重力
v:音速
t:音が反射する時間
E:液体の体積弾性率
いくつかの実施形態では、吸湿性組成物をカテーテル内に含めることができるため、この材料を交換するために空気注入回路を整備する必要はない。
Claims (20)
- 遠位端又はその近くに少なくとも1つの開口部を有するカテーテルと、
前記カテーテルの近位端と流体連通しているバーブと、
前記少なくとも1つの開口部と流体連通するドレナージチューブと、
前記バーブと流体連通する通気管と、
前記通気管と一直線上にかつ前記バーブに対して近位側の位置に配置されている一方向弁と、
前記ドレナージチューブに陰圧を加えることによって前記一方向弁が開放され流体が前記通気管を通過するように制御されるコントローラと、を備えるカテーテルシステム。 - 前記コントローラが、前記一方向弁が閉じられて流体が前記通気管を通過するのを防止されるように前記陰圧を周期的に変えるようにさらにプログラムされている、請求項1に記載のシステム。
- 前記流体は、前記流体が前記通気管を通って前記バーブを介して前記ドレナージチューブに流れるように、開いたときに前記一方向弁を通って受けられることを特徴とする、請求項1に記載のシステム。
- 前記一方向弁を介して受けられる前記流体が大気を含む、請求項3に記載のシステム。
- 前記一方向弁は、前記一方向弁の前後の圧力差が前記一方向弁の所定のクラッキング圧力を超えると開くように構成されている、請求項1に記載のシステム。
- 前記一方向弁は、前記一方向弁の前後の圧力差が前記一方向弁の前記所定のクラッキング圧力を下回ると閉じるようにさらに構成される、請求項5に記載のシステム。
- 前記バーブと前記一方向弁との間に画定される前記通気管の第1の部分は第1の直径および第1の長さを画定し、前記一方向弁の近位に画定される第2の部分は第2の直径及び第2の長さを画定する、請求項1に記載のシステム。
- 前記第1の直径が前記第2の直径よりも小さい、請求項7に記載のシステム。
- 前記第1の長さが前記第2の長さよりも小さい、請求項7に記載のシステム。
- 前記第1の長さおよび前記第2の長さは、前記ドレナージチューブの長さにほぼ等しい、請求項7に記載のシステム。
- 前記第1の直径と前記第2の直径とが等しい、請求項7に記載のシステム。
- 前記第1の直径が4mm未満である、請求項7に記載のシステム。
- 前記第1の直径が2mm未満である、請求項7に記載のシステム。
- 前記第1の直径が0.2~5mmの範囲である、請求項7に記載のシステム。
- 前記第2の直径が2mmより大きい、請求項7に記載のシステム。
- 前記第2の直径が0.2~5mmの範囲である、請求項7に記載のシステム。
- 前記第1の長さが10cm未満である、請求項7に記載のシステム。
- 前記第1の長さが2cmより大きい、請求項7に記載のシステム。
- 前記第1の長さは、5~10cm、10~20cm、20~30cm、または30~50cmの範囲である、請求項7に記載のシステム。
- 前記第2の長さが50~150cmの範囲である、請求項7に記載のシステム。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022090468A JP2022107781A (ja) | 2017-01-19 | 2022-06-02 | 体液を排出及び分析するためのシステム、デバイス及び方法 |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762448237P | 2017-01-19 | 2017-01-19 | |
US62/448,237 | 2017-01-19 | ||
US201762503209P | 2017-05-08 | 2017-05-08 | |
US62/503,209 | 2017-05-08 | ||
US201762563546P | 2017-09-26 | 2017-09-26 | |
US62/563,546 | 2017-09-26 | ||
PCT/US2018/013399 WO2018136306A1 (en) | 2017-01-19 | 2018-01-11 | Systems, devices and methods for draining and analyzing bodily fluids |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022090468A Division JP2022107781A (ja) | 2017-01-19 | 2022-06-02 | 体液を排出及び分析するためのシステム、デバイス及び方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020506748A JP2020506748A (ja) | 2020-03-05 |
JP7084410B2 true JP7084410B2 (ja) | 2022-06-14 |
Family
ID=62909052
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019538523A Active JP7084410B2 (ja) | 2017-01-19 | 2018-01-11 | 体液を排出及び分析するためのシステム、デバイス及び方法 |
JP2022090468A Pending JP2022107781A (ja) | 2017-01-19 | 2022-06-02 | 体液を排出及び分析するためのシステム、デバイス及び方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022090468A Pending JP2022107781A (ja) | 2017-01-19 | 2022-06-02 | 体液を排出及び分析するためのシステム、デバイス及び方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20190343445A1 (ja) |
EP (1) | EP3548133A4 (ja) |
JP (2) | JP7084410B2 (ja) |
WO (1) | WO2018136306A1 (ja) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107260304B (zh) | 2011-02-24 | 2024-05-24 | 爱克斯莫医疗有限公司 | 用于组织切除术的混合导管 |
US9655555B2 (en) * | 2011-03-07 | 2017-05-23 | Potrero Medical, Inc. | Sensing foley catheter |
CN106794043B (zh) | 2014-05-18 | 2020-03-13 | 爱克斯莫医疗有限公司 | 使用脉冲激光器进行组织消融的系统 |
US10391275B2 (en) | 2015-11-17 | 2019-08-27 | Potrero Medical, Inc. | Systems, devices and methods for draining and analyzing bodily fluids |
US10799131B2 (en) | 2017-06-03 | 2020-10-13 | Sentinel Medical Technologies, LLC | Catheter for monitoring intrauterine pressure to protect the fallopian tubes |
US10813589B2 (en) | 2017-06-03 | 2020-10-27 | Sentinel Medical Technologies, LLC | Catheter for monitoring uterine contraction pressure |
US11185245B2 (en) | 2017-06-03 | 2021-11-30 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure for muscle compartment syndrome |
US11045143B2 (en) | 2017-06-03 | 2021-06-29 | Sentinel Medical Technologies, LLC | Catheter with connectable hub for monitoring pressure |
US11045128B2 (en) | 2017-06-03 | 2021-06-29 | Sentinel Medical Technologies, LLC | Catheter for monitoring intra-abdominal pressure |
US11400255B1 (en) * | 2018-11-15 | 2022-08-02 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11672457B2 (en) * | 2018-11-24 | 2023-06-13 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure |
US11179083B2 (en) * | 2018-11-28 | 2021-11-23 | Siargs Ltd. | Physiological fluid collection bag with instant data transmission |
GB2579368B (en) * | 2018-11-29 | 2022-11-09 | Nexa Medical Ltd | Wound-dressing conditioning device |
US11779263B2 (en) | 2019-02-08 | 2023-10-10 | Sentinel Medical Technologies, Llc. | Catheter for monitoring intra-abdominal pressure for assessing preeclampsia |
WO2020176946A1 (en) * | 2019-03-07 | 2020-09-10 | Ventora Medical Pty Ltd | Systems, devices and methods for determining laryngopharyngeal pressure and/or lower oesophageal sphincter pressure |
US11730385B2 (en) | 2019-08-08 | 2023-08-22 | Sentinel Medical Technologies, LLC | Cable for use with pressure monitoring catheters |
WO2021087264A1 (en) * | 2019-10-31 | 2021-05-06 | Musc Foundation For Research Development | Ultrasound-based shunt flow detection |
EP4058083A4 (en) * | 2019-12-18 | 2024-07-03 | Potrero Medical Inc | SYSTEMS, DEVICES AND METHODS FOR DRAINAGE AND ANALYSIS OF BODY FLUIDS AND FOR HEALTH ASSESSMENT |
US11559257B2 (en) | 2019-12-23 | 2023-01-24 | Covidien Lp | Catheter insert including one or more sensors |
US11617543B2 (en) | 2019-12-30 | 2023-04-04 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure |
US12097150B2 (en) | 2020-01-31 | 2024-09-24 | C. R. Bard, Inc. | Drainage bag height actuator |
US12042607B2 (en) | 2020-04-23 | 2024-07-23 | Covidien Lp | Catheter with valves |
KR102198014B1 (ko) * | 2020-04-23 | 2021-01-08 | 비손메디칼 주식회사 | 기관 내부 트리트먼트 기능을 구비한 엔도 튜브 및 시스템 |
US11717642B2 (en) | 2020-04-24 | 2023-08-08 | Covidien Lp | Catheter including one or more sensors |
US11744498B2 (en) | 2020-07-17 | 2023-09-05 | Covidien Lp | Catheter system |
EP4192543A1 (en) * | 2020-08-04 | 2023-06-14 | CM Technologies, Inc. | Fecal management systems and methods |
US12121669B2 (en) | 2020-08-14 | 2024-10-22 | C. R. Bard, Inc. | Assisted fluid drainage system |
US11864893B2 (en) | 2020-09-04 | 2024-01-09 | Covidien Lp | Oxygen sensor calibration |
US11872355B2 (en) * | 2020-09-04 | 2024-01-16 | Covidien Lp | Medical device for detecting fluid parameters using fluorescent probes |
US11944737B2 (en) | 2020-11-24 | 2024-04-02 | C. R. Bard, Inc. | Air venting meter lid adapter |
US12109353B2 (en) | 2020-12-04 | 2024-10-08 | C. R. Bard, Inc. | Dynamic pressure response and catheter occlusion system |
US12128188B2 (en) | 2020-12-21 | 2024-10-29 | C. R. Bard, Inc. | Dynamic pressure response system and method for measuring residual fluid |
US11931541B2 (en) | 2021-01-08 | 2024-03-19 | C. R. Bard, Inc. | Connector for selective occlusion of drainage tube |
US11992599B2 (en) | 2021-01-08 | 2024-05-28 | C. R. Bard, Inc. | Urinary drainage system with air pressure apparatus |
CN117120113A (zh) * | 2021-04-14 | 2023-11-24 | 菲兹医疗有限公司 | 尿液产生和其他与尿液有关的参数的测量 |
WO2022266584A1 (en) * | 2021-06-16 | 2022-12-22 | Potrero Medical, Inc. | Systems, devices and methods for draining and analyzing bodily fluids, pressures and assessing health |
CN118159192A (zh) * | 2021-11-10 | 2024-06-07 | C·R·巴德股份有限公司 | 尿排出量监测系统 |
JP7551674B2 (ja) * | 2022-02-08 | 2024-09-17 | 日本ライフライン株式会社 | バルーンカテーテル |
WO2023199208A1 (en) * | 2022-04-12 | 2023-10-19 | Cm Technologies, Inc. | Urine management systems and methods |
US12038322B2 (en) | 2022-06-21 | 2024-07-16 | Eximo Medical Ltd. | Devices and methods for testing ablation systems |
CN115445007B (zh) * | 2022-10-11 | 2024-07-23 | 中国人民解放军西部战区总医院 | 一种外科护理用术后引流装置 |
WO2024151250A1 (en) * | 2023-01-10 | 2024-07-18 | C. R. Bard, Inc. | Drainage bag with vacuum metering chamber |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007515192A (ja) | 2003-12-22 | 2007-06-14 | メデラ ホールディング アーゲー | 排液装置および方法 |
US20130218106A1 (en) | 2010-07-30 | 2013-08-22 | C. R. Bard, Inc. | Automated Method of Pooling Elimination with a Biological Fluid Collection System |
WO2016049654A1 (en) | 2014-09-28 | 2016-03-31 | Potrero Medical, Inc. | Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4957487A (en) * | 1988-12-30 | 1990-09-18 | Baylor College Of Medicine | External male urinary catheter and collection system |
US5370610A (en) * | 1993-02-09 | 1994-12-06 | Reynolds; James R. | Surgical drainage tube system |
DE4306478A1 (de) * | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainagevorrichtung, insbesondere Pleuradrainagevorrichtung, und Drainageverfahren |
JP2003028098A (ja) * | 2001-07-17 | 2003-01-29 | Japan Science & Technology Corp | ポンプレス吸引器 |
WO2005096753A2 (en) * | 2004-04-02 | 2005-10-20 | The Regents Of The University Of California | Device and systems for the intermittent drainage of urine and other biological fluids |
EP1919533A1 (en) * | 2005-07-24 | 2008-05-14 | Carmeli Adahan | Suctioning system, method and kit |
CA2953011A1 (en) * | 2008-05-16 | 2009-11-19 | Maurice Garcia | Catheter drainage system |
EP3092029A4 (en) * | 2014-01-07 | 2017-09-20 | Consano, Inc. | Systems, devices and methods for draining and analyzing bodily fluids |
US10391275B2 (en) * | 2015-11-17 | 2019-08-27 | Potrero Medical, Inc. | Systems, devices and methods for draining and analyzing bodily fluids |
-
2018
- 2018-01-11 JP JP2019538523A patent/JP7084410B2/ja active Active
- 2018-01-11 WO PCT/US2018/013399 patent/WO2018136306A1/en unknown
- 2018-01-11 EP EP18741234.1A patent/EP3548133A4/en active Pending
-
2019
- 2019-06-26 US US16/452,927 patent/US20190343445A1/en active Pending
-
2022
- 2022-06-02 JP JP2022090468A patent/JP2022107781A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007515192A (ja) | 2003-12-22 | 2007-06-14 | メデラ ホールディング アーゲー | 排液装置および方法 |
US20130218106A1 (en) | 2010-07-30 | 2013-08-22 | C. R. Bard, Inc. | Automated Method of Pooling Elimination with a Biological Fluid Collection System |
WO2016049654A1 (en) | 2014-09-28 | 2016-03-31 | Potrero Medical, Inc. | Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids |
Also Published As
Publication number | Publication date |
---|---|
US20190343445A1 (en) | 2019-11-14 |
JP2022107781A (ja) | 2022-07-22 |
EP3548133A1 (en) | 2019-10-09 |
JP2020506748A (ja) | 2020-03-05 |
EP3548133A4 (en) | 2020-09-09 |
WO2018136306A1 (en) | 2018-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7084410B2 (ja) | 体液を排出及び分析するためのシステム、デバイス及び方法 | |
AU2021201072B2 (en) | Systems, devices and methods for draining and analyzing bodily fluids | |
JP7257994B2 (ja) | 生理学的データを感知し、体液を排出しかつ分析するためのシステム | |
JP7560583B2 (ja) | 体液の排出および分析、並びに健康の評価のためのシステム | |
JP2023507149A (ja) | 体液の排出および分析並びに健康状態を評価するためのシステム、装置、および方法 | |
US12114978B2 (en) | Systems, devices and methods for draining and analyzing bodily fluids and assessing health | |
US20240099624A1 (en) | Systems, devices and methods for draining and analyzing bodily fluids, pressures and assessing health | |
CN112165899B (zh) | 用于排出和分析体液并评估健康的系统、设备和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190930 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190930 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200925 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210713 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20211001 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20211207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211213 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220510 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220602 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7084410 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |